Genomics

Dataset Information

Immunologically active phenotype is associated with response to PD-1/PD-L1 inhibitors in patients with advanced non-small cell lung cancer


ABSTRACT: Immunologically active phenotype is associated with response to PD-1/PD-L1 inhibitors in patients with advanced non-small cell lung cancer

PROVIDER: PRJNA682139 | ENA |

REPOSITORIES: ENA